MedTrace Logo

Radicle Sleep: A Study of Plant Derived Cannabinoids on Sleep and Overall Health Outcomes

NCT05552898 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1750

Last updated 2023-11-22

No results posted yet for this study

Summary

A randomized, blinded, controlled, direct-to-consumer study assessing the impact of plant derived cannabinoids on sleep and overall health outcomes

Conditions

  • Sleep

Interventions

DIETARY_SUPPLEMENT

Sleep Study Product Usage

Participants will use their Radicle Sleep study product as directed for a period of 4 weeks.

Sponsors & Collaborators

  • Radicle Science

    lead INDUSTRY

Principal Investigators

  • Emily K Pauli, PharmD · Radicle Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2022-05-31
Completion
2022-08-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05552898 on ClinicalTrials.gov